Literature DB >> 13896294

Reversible hyponatremia and azotemia in a patient with cirrhosis and ascites.

J T GALAMBOS, H A WILKINSON.   

Abstract

Entities:  

Keywords:  ASCITES/complications; LIVER CIRRHOSIS/complications; SODIUM/blood; UREMIA/etiology

Mesh:

Substances:

Year:  1962        PMID: 13896294     DOI: 10.1007/bf02232779

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  5 in total

1.  Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225].

Authors:  Vicente Arroyo
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

2.  [Hyponatremic syndrome after salt-free diet, enforced diuresis and/or paracentesis for ascites in chronic liver insufficiency; hyponatremia, hypochloremia, hyperkalemia and azotemia].

Authors:  G A MARTINI; J G RAUSCH-STROOMANN
Journal:  Klin Wochenschr       Date:  1959-04-01

3.  Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features.

Authors:  S PAPPER; J L BELSKY; K H BLEIFER
Journal:  Ann Intern Med       Date:  1959-10       Impact factor: 25.391

4.  Renal failure associated with low extracellular sodium chloride; the low salt syndrome.

Authors:  H A SCHROEDER
Journal:  J Am Med Assoc       Date:  1949-09-10

5.  Hyponatremia in hepatic cirrhosis following paracentesis.

Authors:  W P NELSON; J D ROSENBAUM; M B STRAUSS
Journal:  J Clin Invest       Date:  1951-07       Impact factor: 14.808

  5 in total
  3 in total

1.  The hepatorenal syndrome: recovery after portacaval shunt.

Authors:  S Ariyan; T Sweeney; M D Kerstein
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

Review 2.  Renal changes in cirrhosis.

Authors:  M Kew
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

3.  Renal failure following portasystemic shunt in patients with cirrhosis of the liver.

Authors:  J C Garrett; A B Voorhees; S C Sommers
Journal:  Ann Surg       Date:  1970-08       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.